Cyteir Therapeutics, Inc.
USD3.02
-0.07 (-2.27%)
CEO
Markus F. Renschler
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.03
Prev. Close
$3.09
Day Low
$3.00
Day High
$3.09
52W Low
$1.65
52W High
$3.19
Market Cap
$0.11B
Volume
1.01M
| -9.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 43.4% | -151.6% | 0.00 | 3.87 | -20.0 |
| 31 Dec 2019 | FY | -58.6% | -188050.0% | 53.1% | -48.0% | 0.00 | 15.43 | -22.5 |
| -2.8 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -8.6% | -8.3% | 0.00 | 34.94 | -1.4 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -5.1% | -4.8% | 0.01 | 28.07 | -2.0 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -6.7% | -6.4% | 0.01 | 27.05 | -1.6 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -7.3% | -6.9% | 0.01 | 19.95 | -2.2 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -8.1% | -7.6% | 0.01 | 19.77 | -2.4 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -6.3% | -6.0% | 0.00 | 25.71 | -8.5 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -5.9% | -5.7% | 0.00 | 27.12 | -13.1 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -5.8% | -5.6% | 0.00 | 26.91 | -16.5 |